Skip to content
Search

Latest Stories

3 in 5 cancer patients in England now diagnosed at early stage - NHS analysis

Early cancer diagnosis in England has reached its highest level ever.
Colon cancer blood test, conceptual image. (gettyimages)

The TLHC programme led to the earlier diagnosis of over 5,000 people with lung cancer since its launch in 2019

More cancers are being detected earlier in England, thanks to a major drive by the NHS encouraging people, particularly those at higher risk due to hereditary or lifestyle factors, to come forward for potentially life-saving screenings.

According to a new NHS analysis, early cancer diagnosis in England has reached its highest level ever.


The NHS data of the most common cancers, including breast, prostate, and lung cancer, shows that almost three in five patients are now being diagnosed at stages one or two, when the cancer is more treatable.

More than 58 per cent of all common cancers (206,038) diagnosed between September 2023 and August 2024 were identified at an early stage.

This marks a 2.7 percentage point improvement compared to pre-pandemic levels, equating to an estimated 7,000 more patients being diagnosed at an early stage.

The NHS has introduced initiatives like the Targeted Lung Health Check (TLHC) and Liver Health Programmes to detect cancers earlier.

These programmes use mobile scanning trucks and vans that go into the heart of communities, offering in-depth checks to people at shopping centres, sports stadiums, food banks and supermarket car parks.

Since its launch in 2019, the TLHC programme has led to the earlier diagnosis of over 5,000 people with lung cancer, NHSE data reveals.

“Lives are saved when cancers are caught early,” said Dame Cally Palmer, national cancer director for NHS England, highlighting the benefits of the early cancer detection drive.

“There is still much more to do to save more lives and we will not let up in our efforts to catch more cancers earlier, where treatment is more likely to be successful.”

“NHS teams across the country are continuing to take tests and checks closer to people who need them, and with new treatments being made available all the time, we will continue to do all we can to get people seen and treated for cancer as early as possible,” he added.

Professor Peter Johnson, NHS England’s national clinical director for cancer, noted that as life expectancy increases and the number of people developing cancer continues to rise, the NHS diagnosing more cancers than ever before.

He encourages people who suspect they might have signs or symptoms of cancer to get checked so that they can get treatment promptly.

According to Cancer Research UK, lung cancer is the most common cause of cancer death in the UK, accounting for about 21 per cent of all cancer deaths in females and males combined (2017-2019). The next most common causes of cancer death are bowel cancer (10 per cent ), followed by prostate cancer, and breast cancer (both responsible for about seven per cent of all cancer fatalities).

More For You

Youth vaping : project to examine health impacts on children

Youth vaping : project to examine health impacts on children

Youth vaping: £62M research project to examine health impacts on children

The UK government has announced a £62 million research project to investigate the long-term health effects of vaping on young people, alongside wider influences on adolescent health and wellbeing.

While vaping is considered less harmful than smoking and can aid adult smokers in quitting, youth vaping has skyrocketed in recent years, with a quarter of 11 to 15-year-olds having tried it, the Department of Health and Social Care (DHSC) noted in a release.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less